COAGULATION FACTOR IX RECOMBINANT HUMAN for Factor viii deficiency: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 24 adverse event reports in the FDA FAERS database where COAGULATION FACTOR IX RECOMBINANT HUMAN was used for Factor viii deficiency.
Most Reported Side Effects for COAGULATION FACTOR IX RECOMBINANT HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemarthrosis | 318 | 29.8% | 2 | 48 |
| Haemorrhage | 261 | 24.5% | 1 | 34 |
| No adverse event | 97 | 9.1% | 0 | 4 |
| Traumatic haemorrhage | 62 | 5.8% | 1 | 11 |
| Fall | 61 | 5.7% | 0 | 14 |
| Drug ineffective | 60 | 5.6% | 1 | 6 |
| Muscle haemorrhage | 54 | 5.1% | 0 | 12 |
| Arthralgia | 52 | 4.9% | 0 | 6 |
| Contusion | 52 | 4.9% | 0 | 5 |
| Device issue | 43 | 4.0% | 0 | 0 |
| Product preparation issue | 39 | 3.7% | 0 | 0 |
| Head injury | 33 | 3.1% | 0 | 5 |
| Joint swelling | 32 | 3.0% | 0 | 6 |
| Pain | 31 | 2.9% | 1 | 10 |
| Epistaxis | 29 | 2.7% | 0 | 3 |
Other Indications for COAGULATION FACTOR IX RECOMBINANT HUMAN
Factor ix deficiency (758)
Prophylaxis (239)
Product used for unknown indication (88)
Haemorrhage (65)
Haemorrhage prophylaxis (52)
Haemarthrosis (26)
Haemophilia (25)
Haemostasis (22)
Haemorrhagic diathesis (8)
Traumatic haemorrhage (6)
Other Drugs Used for Factor viii deficiency
EMICIZUMAB-KXWH (6,532)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (4,268)
EFMOROCTOCOG ALFA (832)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (722)
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (352)
ANTI-INHIBITOR COAGULANT COMPLEX (317)
EMICIZUMAB (315)
DAMOCTOCOG ALFA PEGOL (310)
EFANESOCTOCOG ALFA (292)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (180)